| 摘要 |
Abstract The present invention relates to stable compositions comprising a sphingosine 1 phosphate (S1P) receptor modulator, suitable for use as a dosage form. The SIP receptor modulators are typically sphingosine analogues,.such as 2-substituted 2-amino- propane 1,3-diol or 2-amino-propanol derivatives, e. g. a compound comprising a group of formula. |
